Corrigendum to ‘Rivaroxaban for the treatment of venous thromboembolism. A 'real-life' perspective in 103 patients’ [Thrombosis Research 134 (2014) 617–621]

MLA

Emilia Barrot-Cortes, et al. “Corrigendum to ‘Rivaroxaban for the Treatment of Venous Thromboembolism. A “Real-Life” Perspective in 103 Patients’ [Thrombosis Research 134 (2014) 617–621].” Thrombosis Research, vol. 136, July 2015, p. 182. EBSCOhost, https://doi.org/10.1016/j.thromres.2015.03.024.

APA

Emilia Barrot-Cortes, Maria Isabel Asensio-Cruz, Teresa Elias-Hernandez, Luis Jara-Palomares, Raquel Sanchez-Oro-Gomez, Marta Ferrer-Galvan, Raquel Morillo-Guerrero, & Remedios Otero-Candelera. (2015). Corrigendum to ‘Rivaroxaban for the treatment of venous thromboembolism. A “real-life” perspective in 103 patients’ [Thrombosis Research 134 (2014) 617–621]. Thrombosis Research, 136, 182. https://doi.org/10.1016/j.thromres.2015.03.024

Chicago

Emilia Barrot-Cortes, Maria Isabel Asensio-Cruz, Teresa Elias-Hernandez, Luis Jara-Palomares, Raquel Sanchez-Oro-Gomez, Marta Ferrer-Galvan, Raquel Morillo-Guerrero, and Remedios Otero-Candelera. 2015. “Corrigendum to ‘Rivaroxaban for the Treatment of Venous Thromboembolism. A “Real-Life” Perspective in 103 Patients’ [Thrombosis Research 134 (2014) 617–621].” Thrombosis Research 136 (July): 182. doi:10.1016/j.thromres.2015.03.024.